The Patent Finder

Bionorica SE

Also on record
Records under this name other than the patents Bionorica SE holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.

Back to Bionorica SE

PatentTitleStatus Expires Confidence
US 8,337,908Plant Extract from Low-Thc Cannabis for the Treatment of Disease
Lapsed on the fee record
Ended Dec 25, 2024 · High confidence
Lapsed on the fee recordEnded Dec 25, 2024High confidence
US 8,324,408Method for the preparation of dronabinol
Formerly held
Lapsed on the fee record
Ended Dec 4, 2024 · From the USPTO record
Lapsed on the fee recordEnded Dec 4, 2024From the USPTO record
US 10,603,344Plant Extract from Low-Thc Cannabis for the Treatment of Disease
Lapsed on the fee record
Ended Mar 31, 2024 · High confidence
Lapsed on the fee recordEnded Mar 31, 2024High confidence
US 6,996,919Process for obtaining dry extracts under mild conditions
Term ended
Term ended Aug 10, 2022 · From the USPTO record
Term endedTerm ended Aug 10, 2022From the USPTO record
US 7,291,250Vacuum distillation system and use thereof for concentrating organic-aqueous solvent mixtures
Term ended
Term ended Oct 20, 2019 · From the USPTO record
Term endedTerm ended Oct 20, 2019From the USPTO record
US 7,244,902Method for classifying wine and coffee
Lapsed on the fee record
Ended Jul 17, 2019 · From the USPTO record
Lapsed on the fee recordEnded Jul 17, 2019From the USPTO record
US 8,734,857Hydrolysates made of plant extracts and antibacterial agent containing the same
Lapsed on the fee record
Ended May 27, 2018 · From the USPTO record
Lapsed on the fee recordEnded May 27, 2018From the USPTO record
US 7,715,002Method for classifying scientific materials such as silicate materials, polymer materials and/or nanomaterials
Lapsed on the fee record
Ended May 11, 2018 · From the USPTO record
Lapsed on the fee recordEnded May 11, 2018From the USPTO record
US 7,629,005Pharmaceutical formulation consisting of a plant dry extract with a calcium coating
Lapsed on the fee record
Ended Dec 8, 2017 · From the USPTO record
Lapsed on the fee recordEnded Dec 8, 2017From the USPTO record
US 7,413,754Use of extracts of the genus Cimicifugaas organoselective medicines for treating diseases of the genitourinary system caused by sex hormones
Lapsed on the fee record
Ended Aug 19, 2016 · From the USPTO record
Lapsed on the fee recordEnded Aug 19, 2016From the USPTO record
10 of 15 patents shown.
Pro members see all 15.
Pro members: see all 15 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited